Pediatric Studies Delayed Mostly By FDA Red Tape, Companies Say
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA posts non-compliance letters and responses from three sponsors that failed to meet deadlines for submitting reports for trials of four drugs in children; more than 70 firms have had their deadlines extended.